Interv Akut Kardiol. 2011;10(4):187-190
Causal therapy of valvular heart disease falls within the realm of cardiac surgery. A number of patients with valvular heart disease concurrently
suffer from arterial hypertension – they are either patients with a defect that has not yet been indicated for surgery or those
in whom a conservative approach has been chosen due to high surgical risk. When treating arterial hypertension in these patients, it is
often possible to select antihypertensive agents with a certain „added value“ in terms of affecting the symptoms of valvular disease and
left ventricular volumes. These include, in particular, ACE inhibitors in aortic and mitral regurgitation. This group of medications is no
longer prohibited in treating hypertension in patients with aortic stenosis; however, the presumed positive effect on slowing down the
progression of valvular heart disease itself has not been demonstrated.
Published: July 1, 2011 Show citation